Optimised to detect abnormal breathing associated with opioid induced respiratory depression (OIRD)
Our specially designed wireless biosensor is one of the smallest available. It transmits data to the cloud using a smartphone or tablet.
Biosensor data is analysed in the cloud by algorithms that use machine learning to enhance accuracy.
Where signs of overdose are detected, nearby responders are alerted to check the patient.
Overdose monitoring and alerting will maximise the use of naloxone, the highly effective opioid reversal agent.
Designed for home use or in a healthcare setting.
Note: Performance characteristics are not yet established
– Altair Medical, developing a groundbreaking solution to the global opioid crisis today announces that the FDA have awarded the company Breakthrough Medical Device Status for its RESPMETERTM wearable biosensor device.